Hepatocellular carcinoma (HCC) represents about 90% of all cases of liver cancer and has a poor prognosis, with a 5-year survival rate of about 18%. Previous findings had shown that RNA ...

While radiotherapy is a highly effective cancer treatment — useful for about 60 per cent of all cancers — it may lead to ...

HealthDay News — For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma (HCC) and hepatic decompensation, according to a study published ...

Despite appearing successful on scans, radiotherapy may leave behind undetected microscopic cancer cells, posing a greater risk of recurrence and worse long-term outcomes than previously thought, ...

"Residual cancer is identified on histology in 40% of lung, 57–69% of renal cell, 7.7–47.6% of prostate and 0–86.7% of hepatocellular carcinoma." ...

Discover how Yttrium-90 radioembolisation may offer improved survival for large hepatocellular carcinoma tumours compared to ...

Hepatitis C virus (HCV) infection remains a major global health burden, affecting millions worldwide and contributing significantly to hepatocellular carcinoma (HCC) development.

An OLYMPUS CKX53 (OLYMPUS, Shinjuku, Tokyo, Japan) digital microscope was utilized for image photographing ... 3,3'-diindolylmethane suppresses the growth of hepatocellular carcinoma by regulating its ...

A medullary carcinoma of the thyroid gland was examined by electron microscopy, histochemistry and bioassay for thyrocalcitonin. Numerous secretory granules were present in the cytoplasm of the ...

Version of Record: This is the final version of the article. This study investigated the role of PLECTIN, a cytoskeletal crosslinker protein, in liver cancer formation and progression. Using the liver ...

Hepatocellular carcinoma (HCC) is a major global health issue, with significant morbidity and mortality rates. As the sixth most common cancer and the third leading cause of cancer-related deaths ...